Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Adolescent and Young Adult Cancer Survivors: Identity Development
- Conditions
- Cancer
- Interventions
- Behavioral: interviewBehavioral: Focus groupsBehavioral: Questionnaire
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 300
- Registration Number
- NCT00832325
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
- Conditions
- Colon Cancer
- Interventions
- Drug: FOLFOX and bevacizumab
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT00826800
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- Conditions
- Breast Cancer
- Interventions
- Other: Blood draw and questionnaires
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 609
- Registration Number
- NCT00823654
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2019-08-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT00820170
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L
- Conditions
- Multiple Myeloma
- Interventions
- Procedure: Stem cell transplant x 1 or x 2
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2019-03-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 67
- Registration Number
- NCT00807599
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00807573
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital, Sleepy Hollow, New York, United States
🇺🇸Memorial Sloan-Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
- Conditions
- Bladder CancerMetastatic Transitional Cell Carcinoma
- Interventions
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00805129
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Penile Exam, Peyronie's Plaque and Erectile function assessment
- First Posted Date
- 2008-12-02
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 121
- Registration Number
- NCT00800813
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of Vaginal Dilator Use After Pelvic Radiotherapy
- Conditions
- Endometrial CancerAnal CancerRectal CancerCervical Cancer
- Interventions
- Device: Vaginal Dilator
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 115
- Registration Number
- NCT00789893
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
- Conditions
- Malignant GliomaBrain Cancer
- Interventions
- Other: radiotherapy (RT) in combination with temozolomide and bevacizumab
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00782756
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States